BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31048007)

  • 1. CRISPR-Cas9 genome editing approaches in filamentous fungi and oomycetes.
    Schuster M; Kahmann R
    Fungal Genet Biol; 2019 Sep; 130():43-53. PubMed ID: 31048007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-based genome engineering: A new breakthrough in the genetic manipulation of filamentous fungi.
    Ullah M; Xia L; Xie S; Sun S
    Biotechnol Appl Biochem; 2020 Nov; 67(6):835-851. PubMed ID: 33179815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9 genome editing technology in filamentous fungi: progress and perspective.
    Song R; Zhai Q; Sun L; Huang E; Zhang Y; Zhu Y; Guo Q; Tian Y; Zhao B; Lu H
    Appl Microbiol Biotechnol; 2019 Sep; 103(17):6919-6932. PubMed ID: 31332488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9-based genome editing of the filamentous fungi: the state of the art.
    Shi TQ; Liu GN; Ji RY; Shi K; Song P; Ren LJ; Huang H; Ji XJ
    Appl Microbiol Biotechnol; 2017 Oct; 101(20):7435-7443. PubMed ID: 28887634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of CRISPR/Cas9 in genome editing of filamentous fungi.
    Li HH; Liu G
    Yi Chuan; 2017 May; 39(5):355-367. PubMed ID: 28487268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing CRISPR-Cas for oomycete genome editing.
    Vink JNA; Hayhurst M; Gerth ML
    Trends Microbiol; 2023 Sep; 31(9):947-958. PubMed ID: 37127441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a genome editing technique using the CRISPR/Cas9 system in the industrial filamentous fungus Aspergillus oryzae.
    Katayama T; Tanaka Y; Okabe T; Nakamura H; Fujii W; Kitamoto K; Maruyama J
    Biotechnol Lett; 2016 Apr; 38(4):637-42. PubMed ID: 26687199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forced Recycling of an AMA1-Based Genome-Editing Plasmid Allows for Efficient Multiple Gene Deletion/Integration in the Industrial Filamentous Fungus
    Katayama T; Nakamura H; Zhang Y; Pascal A; Fujii W; Maruyama JI
    Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome editing approaches: manipulating of lovastatin and taxol synthesis of filamentous fungi by CRISPR/Cas9 system.
    El-Sayed ASA; Abdel-Ghany SE; Ali GS
    Appl Microbiol Biotechnol; 2017 May; 101(10):3953-3976. PubMed ID: 28389711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-Based Genome Editing in the Filamentous Fungus Fusarium fujikuroi and Its Application in Strain Engineering for Gibberellic Acid Production.
    Shi TQ; Gao J; Wang WJ; Wang KF; Xu GQ; Huang H; Ji XJ
    ACS Synth Biol; 2019 Feb; 8(2):445-454. PubMed ID: 30616338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights of CRISPR technology in human pathogenic fungi.
    Román E; Prieto D; Alonso-Monge R; Pla J
    Future Microbiol; 2019 Sep; 14():1243-1255. PubMed ID: 31625446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas Genome Editing in Filamentous Fungi.
    Rozhkova AM; Kislitsin VY
    Biochemistry (Mosc); 2021 Jan; 86(Suppl 1):S120-S139. PubMed ID: 33827404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of CRISPR/Cas9 in the Synthesis of Secondary Metabolites in Filamentous Fungi.
    Jiang C; Lv G; Tu Y; Cheng X; Duan Y; Zeng B; He B
    Front Microbiol; 2021; 12():638096. PubMed ID: 33643273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular tools for gene manipulation in filamentous fungi.
    Wang S; Chen H; Tang X; Zhang H; Chen W; Chen YQ
    Appl Microbiol Biotechnol; 2017 Nov; 101(22):8063-8075. PubMed ID: 28965220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of CRISPR/Cas gene-editing technology in yeast and fungi.
    Liao B; Chen X; Zhou X; Zhou Y; Shi Y; Ye X; Liao M; Zhou Z; Cheng L; Ren B
    Arch Microbiol; 2021 Dec; 204(1):79. PubMed ID: 34954815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 technology enables the development of the filamentous ascomycete fungus Penicillium subrubescens as a new industrial enzyme producer.
    Salazar-Cerezo S; Kun RS; de Vries RP; Garrigues S
    Enzyme Microb Technol; 2020 Feb; 133():109463. PubMed ID: 31874686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a versatile and conventional technique for gene disruption in filamentous fungi based on CRISPR-Cas9 technology.
    Zheng YM; Lin FL; Gao H; Zou G; Zhang JW; Wang GQ; Chen GD; Zhou ZH; Yao XS; Hu D
    Sci Rep; 2017 Aug; 7(1):9250. PubMed ID: 28835711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of CRISPR in Filamentous Fungi and Macrofungi: From Component Function to Development Potentiality.
    Shen JY; Zhao Q; He QL
    ACS Synth Biol; 2023 Jul; 12(7):1908-1923. PubMed ID: 37404005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR system in filamentous fungi: Current achievements and future directions.
    Deng H; Gao R; Liao X; Cai Y
    Gene; 2017 Sep; 627():212-221. PubMed ID: 28625564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and Challenges: Development and Implementation of CRISPR/Cas9 Technology in Filamentous Fungi.
    Wang Q; Coleman JJ
    Comput Struct Biotechnol J; 2019; 17():761-769. PubMed ID: 31312414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.